Latest Annexin Pharmaceuticals News & Updates

See the latest news and media coverage for Annexin Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Annexin Pharmaceuticals

Clinical-stage biotechnology company developing Annexin A5 therapeutics

annexinpharma.com
Headquarters
Stockholm, Sweden
Founded year
2014
Company type
Public company
Number of employees
5–10

Last updated

Latest news about Annexin Pharmaceuticals

In short: Annexin Pharmaceuticals reported promising results in clinical trials for its drug candidate ANXV and secured new financing for further research.

Company announcements

Annexin Pharmaceuticals

Annexin announces favourable findings in Phase 2a study

First two patients with DR and RVO show no safety issues and signals of efficacy including improved retinal perfusion after ANXV treatment. Study prepares for Phase 2b.

Unlock all announcements with a

Media coverage

Yahoo Finance

Annexin Pharmaceuticals AB (publ) (ANNX.ST)

Get the detailed quarterly/annual income statement for Annexin Pharmaceuticals AB (publ) (ANNX.ST). Find out the revenue, expenses and profit or loss over the last fiscal...

FinanzNachrichten

Annexin Pharmaceuticals AB: Favourable findings in Annexin's ongoing Phase 2a study in Diabetic Retinopathy and Retinal Vein Occlusion

Annexin Pharmaceuticals AB today announces favourable findings in the company's ongoing Proof of Concept Phase 2a study with the drug candidate ANXV in Diabetic Retinopathy...

Unlock all articles with a

Never miss news about Annexin Pharmaceuticals

Track Annexin Pharmaceuticals and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.